The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
EBRD approves loan of up to EUR270 mln for Naftogaz to buy natural gas for next two heating seasons
16:07, 26.03.2025
EBRD may partially cover ProCredit Bank's risks under new loans for EUR70 mln
20:18, 05.03.2025
Zelenskyy discusses support for Ukrainians with EBRD president
18:59, 06.02.2025
Ukrnafta and EBRD plan to build modern combined-cycle CHPP
16:44, 06.02.2025
Ukrainian PM, EBRD President discuss strengthening cooperation in energy, infrastructure
20:04, 04.02.2025
LATEST
Nova Poshta to boost European investment by 42.8% in 2025 – CEO of Nova Post Europe
19:01, 04.04.2025
Vodafone Ukraine sees 30.1% drop in net profit in 2024 despite 13.1% revenue growth
18:03, 04.04.2025
Agricultural exports account for over 50% of all Ukrainian exports - Shmyhal
14:38, 04.04.2025
Epicentr Ceramic Corporation plans to increase share of product exports to 30% in 2025
10:31, 04.04.2025
Epicentr Ceramic Corporation increases production by 25.3% in 2024